In addition, MLN4924 suppressed survival and self-renewal of human CML CD34+ cells, and inhibited LSCs in CML-bearing mice through accumulation of p27kip185. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.